Atypical pantothenate kinase-associated neurodegeneration with PANK2 mutations : clinical description and a review of the literature

References

• Abbruzzese, G. , Cossu, G. , Balocco, M. , Marchese, R. , Murgia, D. , Melis, M. , Galanello, R. , Barella, S. , Matta, G. , Ruffinengo, U. , Bonuccelli, U. , & Forni, G. L. (2011). A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica , 96(11), 1708–1711. https://doi.org/10.3324/haematol.2011.043018
   PubMed Web of Science ®Google Scholar
• Akcakaya, N. H. , Iseri, S. U. , Bilir, B. , Battaloglu, E. , Tekturk, P. , Gultekin, M. , Akar, G. , Yigiter, R. , Hanagasi, H. , Alp, R. , Cagirici, S. , Eraksoy, M. , Ozbek, U. , & Yapici, Z. (2017). Clinical and genetic features of PKAN patients in a tertiary centre in Turkey. Clinical Neurology and Neurosurgery , 154(3), 34–42. https://doi.org/10.1016/j.clineuro.2017.01.011
   Web of Science ®Google Scholar
• Arber, C. E. , Li, A. , Houlden, H. , & Wray, S. (2016). Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: Unifying theories. Neuropathology and Applied Neurobiology , 42(3), 220–241. https://doi.org/10.1111/nan.12242
   PubMed Web of Science ®Google Scholar
• Brezavar, D. , & Bonnen, P. E. (2019). Incidence of PKAN determined by bioinformatic and population-based analysis of ~140,000 humans. Molecular Genetics and Metabolism , 128(4), 463–469. https://doi.org/10.1016/j.ymgme.2019.09.002
   PubMed Web of Science ®Google Scholar
• Brunetti, D. , Dusi, S. , Giordano, C. , Lamperti, C. , Morbin, M. , Fugnanesi, V. , Marchet, S. , Fagiolari, G. , Sibon, O. , Moggio, M. , d’Amati, G. , & Tiranti, V. (2014). Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model. Brain: A Journal of Neurology , 137(1), 57–68. https://doi.org/10.1093/brain/awt325
   PubMedGoogle Scholar
• Cheng, Y. , Liu, Y.-T. , Yang, Z.-H. , Yang, J. , Shi, C.-H. , & Xu, Y.-M. (2018). Novel compound heterozygous PANK2 gene mutations in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration. The International Journal of Neuroscience , 128(12), 1109–1113. https://doi.org/10.1080/00207454.2018.1483364
   PubMed Web of Science ®Google Scholar
• Cossu, G. , Abbruzzese, G. , Matta, G. , Murgia, D. , Melis, M. , Ricchi, V. , Galanello, R. , Barella, S. , Origa, R. , Balocco, M. , Pelosin, E. , Marchese, R. , Ruffinengo, U. , & Forni, G. L. (2014). Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up. Parkinsonism & Related Disorders , 20(6), 651–654. https://doi.org/10.1016/j.parkreldis.2014.03.002
   PubMed Web of Science ®Google Scholar
• Crisci, C. , & Esposito, M. (2011). Efficacy of botulinum toxin A treatment in a case of pantothenate kinase associated neurodegeneration (PKAN). BMJ Case Reports , 2011(aug25 1), bcr0720114514-bcr0720114514. https://doi.org/10.1136/bcr.07.2011.4514
   PubMedGoogle Scholar
• Dressler, D. , Altenmueller, E. , Bhidayasiri, R. , Bohlega, S. , Chana, P. , Chung, T. M. , Frucht, S. , Garcia-Ruiz, P. J. , Kaelin A., Kaji R., Kanovsky P., Laskawi R., Micheli F., Orlova O., Relja M., Rosales R., Slawek J., Timerbaeva S., Warner T. T., Saberi F. A. (2016). Strategies for treatment of dystonia. Journal of Neural Transmission (Vienna, Austria: 1996) , 123(3), 251–258. https://doi.org/10.1007/s00702-015-1453-x
   PubMed Web of Science ®Google Scholar
• Dusi, S. , Valletta, L. , Haack, T. B. , Tsuchiya, Y. , Venco, P. , Pasqualato, S. , Goffrini, P. , Tigano, M. , Demchenko, N. , Wieland, T. , Schwarzmayr, T. , Strom, T. , Invernizzi, F. , Garavaglia, B. , Gregory, A. , Sanford, L. , Hamada, J. , Bettencourt, C. , Houlden, H. , Chiapparini, L. , & Tiranti, V. (2014). Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. The American Journal of Human Genetics , 94(1), 11–22. https://doi.org/10.1016/j.ajhg.2013.11.008
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz, P. J. , Ayerbe, J. , Vela Desojo, L. , Feliz, C. E. , & Del Val Fernandez, J. (2015). Deep brain stimulation for pantothenate kinase-associated neurodegeneration. Case Reports in Neurological Medicine , 2015, 245735. doi: 10.1155/2015/245735
   PubMed Web of Science ®Google Scholar
• Garzuly, F. (2017). [From the Hallervorden-Spatz eponym to the molecular terminology]. Orvosi Hetilap , 158(43), 1723–1727. https://doi.org/10.1556/650.2017.30875
   PubMed Web of Science ®Google Scholar
• Habibi, A. H. , Razmeh, S. , Aryani, O. , Rohani, M. , Taghavian, L. , Alizadeh, E. , Kokhedan, K. M. , & Zaribafian, M. (2019). A novel homozygous variation in the PANK2 gene in two Persian siblings with atypical pantothenate kinase associated neurodegeneration. Neurology International , 11(1), 7959. https://doi.org/10.4081/ni.2019.7959
   PubMed Web of Science ®Google Scholar
• Han, J. , Kim Do, W. , Lee, C.-H. , & Han, S.-H. (2016). Optic atrophy in a patient with atypical pantothenate kinase-associated neurodegeneration. Journal of Neuro-ophthalmology: The Official Journal of the North American Neuro-Ophthalmology Society , 36(2), 182–186. https://doi.org/10.1097/WNO.0000000000000335
   PubMed Web of Science ®Google Scholar
• Hayflick, S. J. , Westaway, S. K. , Levinson, B. , Zhou, B. , Johnson, M. A. , Ching, K. H. , & Gitschier, J. (2003). Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. The New England Journal of Medicine , 348(1), 33–40. https://doi.org/10.1056/NEJMoa020817
   PubMed Web of Science ®Google Scholar
• Hider, R. C. , Roy, S. , Ma, Y. M. , Le Kong, X. , & Preston, J. (2011). The potential application of iron chelators for the treatment of neurodegenerative diseases. Metallomics: Integrated Biometal Science , 3(3), 239–249. https://doi.org/10.1039/c0mt00087f
   PubMed Web of Science ®Google Scholar
• Hogarth, P. (2015). Neurodegeneration with brain iron accumulation: Diagnosis and management. Journal of Movement Disorders , 8(1), 1–13. https://doi.org/10.14802/jmd.14034
   PubMed Web of Science ®Google Scholar
• Kang, A. , & Minoshima, S. (2014). 123I-ioflupane SPECT findings of pantothenate kinase-associated neurodegeneration. Clinical Nuclear Medicine , 39(9), 849–851. https://doi.org/10.1097/RLU.0000000000000409
   PubMed Web of Science ®Google Scholar
• Kurian, M. A. , & Hayflick, S. J. (2013). Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): Review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes. International Review of Neurobiology , 110(3), 49–71.doi: 10.1016/B978-0-12-410502-7.00003-X
   Web of Science ®Google Scholar
• Lee, C.-H. , Lu, C.-S. , Chuang, W.-L. , Yeh, T.-H. , Jung, S.-M. , Huang, C.-L. , & Lai, S.-C. (2013). Phenotypes and genotypes of patients with pantothenate kinase-associated neurodegeneration in Asian and Caucasian populations: 2 cases and literature review. The Scientific World Journal , 2013, 19, 860539. https://doi.org/10.1155/2013/860539
   Google Scholar
• Levi, S. , & Tiranti, V. (2019). Neurodegeneration with brain iron accumulation disorders: Valuable models aimed at understanding the pathogenesis of iron deposition . Pharmaceuticals.
   Google Scholar
• Li, Y. F. , Li, H. F. , Zhang, Y. B. , & Wu, J. M. (2016). Novel homozygous PANK2 mutation identified in a consanguineous Chinese pedigree with pantothenate kinase-associated neurodegeneration. Biomedical Reports , 5(2), 217–220. https://doi.org/10.3892/br.2016.715
   PubMed Web of Science ®Google Scholar
• Lim, B. C. , Ki, C.-S. , Cho, A. , Hwang, H. , Kim, K. J. , Hwang, Y. S. , Kim, Y. E. , Yun, J. Y. , Jeon, B. S. , Lim, Y. H. , Paek, S. H. , & Chae, J. H. (2012). Pantothenate kinase-associated neurodegeneration in Korea: Recurrent R440P mutation in PANK2 and outcome of deep brain stimulation. European Journal of Neurology , 19(4), 556–561. https://doi.org/10.1111/j.1468-1331.2011.03589.x
   PubMed Web of Science ®Google Scholar
• Lin, C. I. , Chen, K. L. , Kuan, T. S. , Lin, S. H. , Lin, W. P. , & Lin, Y. C. (2018). Botulinum toxin injection to improve functional independence and to alleviate parenting stress in a child with advanced pantothenate kinase-associated neurodegeneration: A case report and literature review. Medicine , 97(20), e10709. https://doi.org/10.1097/MD.0000000000010709
   PubMed Web of Science ®Google Scholar
• Mak, C. M. , Sheng, B. , Lee, H. H. , Lau, K. K. , Chan, W. T. , Lam, C. W. , & Chan, Y. W. (2011). Young-onset parkinsonism in a Hong Kong Chinese man with adult-onset Hallervorden-Spatz syndrome. The International Journal of Neuroscience , 121(4), 224–227. https://doi.org/10.3109/00207454.2010.542843
   PubMed Web of Science ®Google Scholar
• McNeill, A. , Birchall, D. , Hayflick, S. J. , Gregory, A. , Schenk, J. F. , Zimmerman, E. A. , Shang, H. , Miyajima, H. , & Chinnery, P. F. (2008). T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology , 70(18), 1614–1619. https://doi.org/10.1212/01.wnl.0000310985.40011.d6
   PubMed Web of Science ®Google Scholar
• Mikati, M. A. , Yehya, A. , Darwish, H. , Karam, P. , & Comair, Y. (2009). Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration. European Journal of Paediatric Neurology: EJPN: Official Journal of the European Paediatric Neurology Society , 13(1), 61–64. https://doi.org/10.1016/j.ejpn.2008.01.006
   PubMed Web of Science ®Google Scholar
• Nunez, M. T. , & Chana-Cuevas, P. (2018). New perspectives in iron chelation therapy for the treatment of neurodegenerative diseases . Pharmaceuticals.
   Google Scholar
• Pan, L. S. , Yu, L. H. , Yin, Y. Y. , & Xu, Y. M. (2013). A novel PANK2 mutation in a 12-year-old Chinese boy with pantothenate kinase-associated neurodegeneration. Neurology India , 61(2), 175–176. https://doi.org/10.4103/0028-3886.111134
   PubMed Web of Science ®Google Scholar
• Pellecchia, M. T. , Valente, E. M. , Cif, L. , Salvi, S. , Albanese, A. , Scarano, V. , Bonuccelli, U. , Bentivoglio, A. R. , D’Amico, A. , Marelli, C. , Di Giorgio, A. , Coubes, P. , Barone, P. , & Dallapiccola, B. (2005). The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology , 64 10, 1810–1812. https://doi.org/10.1212/01.WNL.0000161843.52641.EC
   PubMed Web of Science ®Google Scholar
• Racette, B. A. , Perry, A. , D’Avossa, G. , & Perlmutter, J. S. (2001). Late-onset neurodegeneration with brain iron accumulation type 1: Expanding the clinical spectrum. Movement Disorders: Official Journal of the Movement Disorder Society , 16(6), 1148–1152. https://doi.org/10.1002/mds.10012
   PubMed Web of Science ®Google Scholar
• Rana, A. , Seinen, E. , Siudeja, K. , Muntendam, R. , Srinivasan, B. , van der Want, J. J. , Hayflick, S. , Reijngoud, D.-J. , Kayser, O. , & Sibon, O. C. M. (2010). Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America , 107(15), 6988–6993. https://doi.org/10.1073/pnas.0912105107
   PubMed Web of Science ®Google Scholar
• Rohani, M. , Fasano, A. , Lang, A. E. , Zamani, B. , Javanparast, L. , Bidgoli, M. R. , & Alavi, A. (2018). Pantothenate kinase-associated neurodegeneration mimicking Tourette syndrome: A case report and review of the literature. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology , 39(10), 1797–1800. https://doi.org/10.1007/s10072-018-3472-5
   PubMed Web of Science ®Google Scholar
• Seo, J. H. , song, S. K. , & Lee, P. H. (2009). A novel PANK2 mutation in a patient with atypical pantothenate-kinase-associated neurodegeneration presenting with adult-onset parkinsonism. Journal of Clinical Neurology (Seoul, Korea) , 5(4), 192–194. https://doi.org/10.3988/jcn.2009.5.4.192
   PubMed Web of Science ®Google Scholar
• Shan, J. , Wen, B. , Zhu, J. , Lin, P. , Zheng, J. , & Yan, C. (2013). Novel PANK2 gene mutations in two Chinese siblings with atypical pantothenate kinase-associated neurodegeneration. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology , 34(4), 561–563. https://doi.org/10.1007/s10072-012-1177-8
   PubMed Web of Science ®Google Scholar
• Shi, X. , Zheng, F. , Ye, X. , Li, X. , Zhao, Q. , Lin, Z. , Hu, Y. , & Wang, J. (2018). Basal ganglia calcification and novel compound heterozygous mutations in the PANK2 gene in a Chinese boy with classic Pantothenate kinase-associated neurodegeneration: A case report. Medicine , 97(15), e0316. https://doi.org/10.1097/MD.0000000000010316
   PubMed Web of Science ®Google Scholar
• Song, X. W. , Wang, Y. L. , Shi, Y. W. , Deng, W. Y. , Chen, S. Q. , Lin, H. , Yi, Y. H. , & Liao, W. P. (2009). Clinical manifestations and detection of pantothenate kinase 2 gene mutation in a patient with Hallervorden-Spatz syndrome. Zhonghua yi xue za zhi , 89(47), 3320–3323.
   PubMedGoogle Scholar
• Swaiman, K. F. (1991). Hallervorden-Spatz syndrome and brain iron metabolism. Archives of Neurology , 48(12), 1285–1293. https://doi.org/10.1001/archneur.1991.00530240091029
   PubMedGoogle Scholar
• Swaiman, K. F. (2001). Hallervorden-Spatz syndrome. Pediatric Neurology , 25(2), 102–108. https://doi.org/10.1016/S0887-8994(01)00253-3
   PubMed Web of Science ®Google Scholar
• Tanrikulu, B. , Ozen, A. , Gunal, D. I. , Turkdogan, D. , Bayrakli, F. , Bayri, Y. , Dagcinar, A. , & Seker, A. (2015). Deep brain stimulation as treatment for dystonic storm in pantothenate kinase-associated neurodegeneration syndrome: Case report of a patient with homozygous C.628 2 T > G mutation of the PANK2 gene. Acta neurochirurgica , 157(9), 1513–1516. discussion 1516-1517. https://doi.org/10.1007/s00701-015-2514-5
   PubMed Web of Science ®Google Scholar
• Taylor, T. D. , Litt, M. , Kramer, P. , Pandolfo, M. , Angelini, L. , Nardocci, N. , Davis, S. , Pineda, M. , Hattori, H. , Flett, P. J. , Cilio, M. R. , Bertini, E. , & Hayflick, S. J. (1996). Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nature Genetics , 14(4), 479–481. https://doi.org/10.1038/ng1296-479
   PubMed Web of Science ®Google Scholar
• Tonekaboni, S. H. , & Mollamohammadi, M. (2014). Neurodegeneration with brain iron accumulation: An overview. Iranian Journal of Child Neurology , 8(4), 1–8.
   PubMedGoogle Scholar
• Vasconcelos, O. M. , Harter, D. H. , Duffy, C. , McDonough, B. , Seidman, J. G. , Seidman, C. E. , & Campbell, W. W. (2003). Adult Hallervorden-Spatz syndrome simulating amyotrophic lateral sclerosis. Muscle & Nerve , 28(1), 118–122. https://doi.org/10.1002/mus.10389
   PubMed Web of Science ®Google Scholar
• Williams, S. , Gregory, A. , Hogarth, P. , Hayflick, S. J. , & Gillingham, M. B. (2013). Metabolism and energy requirements in pantothenate kinase-associated neurodegeneration. Molecular Genetics and Metabolism , 110(3), 336–341. https://doi.org/10.1016/j.ymgme.2013.06.017
   PubMed Web of Science ®Google Scholar
• Wu, Y. R. , Chen, C. M. , Chao, C. Y. , Lyu, R. K. , & Lee-Chen, G. J. (2009). Pantothenate kinase-associated neurodegeneration in two Taiwanese siblings: Identification of a novel PANK2 gene mutation. Movement Disorders: Official Journal of the Movement Disorder Society , 24(6), 940–941. https://doi.org/10.1002/mds.22458
   PubMed Web of Science ®Google Scholar
• Zeng, J. , Xing, W. , Liao, W. , & Wang, X. (2019). Magnetic resonance imaging, susceptibility weighted imaging and quantitative susceptibility mapping findings of pantothenate kinase-associated neurodegeneration. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia , 59(1), 20–28. https://doi.org/10.1016/j.jocn.2018.10.090
   Web of Science ®Google Scholar
• Zhang, Y. , Tang, B. , Guo, J. , Long, Z. , Xia, K. , Pan, Q. , Hu, Z. , Wu, D. , Tang, J. , Chen, T. , & Yan, X. (2005). Studies on PANK2 gene mutations in Chinese patients with Hallervorden-Spatz syndrome. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics , 22(2), 189–191.
   PubMedGoogle Scholar
• Zhang, Y. , Zhou, D. , & Yang, T. (2019). Novel PANK2 mutation in a Chinese boy with PANK2-associated neurodegeneration: A case report and review of Chinese cases. Medicine , 98(4), e14122. https://doi.org/10.1097/MD.0000000000014122
   PubMed Web of Science ®Google Scholar
• Zorzi, G. , & Nardocci, N. (2013). Therapeutic advances in neurodegeneration with brain iron accumulation. International Review of Neurobiology , 110(3), 153–164. doi: 10.1016/B978-0-12-410502-7.00008-9
   Web of Science ®Google Scholar
• Zorzi, G. , Zibordi, F. , Chiapparini, L. , Bertini, E. , Russo, L. , Piga, A. , Longo, F. , Garavaglia, B. , Aquino, D. , Savoiardo, M. , Solari, A. , & Nardocci, N. (2011). Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial. Movement Disorders: Official Journal of the Movement Disorder Society , 26(9), 1756–1759. https://doi.org/10.1002/mds.23751
   PubMed Web of Science ®Google Scholar